260 related articles for article (PubMed ID: 32000551)
1. Efficacy and safety of tocilizumab in treatment of Takayasu arteritis: A systematic review of randomized controlled trials.
Singh A; Danda D; Hussain S; Najmi AK; Mathew A; Goel R; Lakhan SE; Tajudheen B; Antony B
Mod Rheumatol; 2021 Jan; 31(1):197-204. PubMed ID: 32000551
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
Nakaoka Y; Isobe M; Takei S; Tanaka Y; Ishii T; Yokota S; Nomura A; Yoshida S; Nishimoto N
Ann Rheum Dis; 2018 Mar; 77(3):348-354. PubMed ID: 29191819
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of biological agents in the treatment of patients with Takayasu arteritis: a systematic review and meta-analysis.
Shuai ZQ; Zhang CX; Shuai ZW; Ge SL
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):250-262. PubMed ID: 33506914
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
Pan L; Du J; Liu J; Liao H; Liu X; Guo X; Liang J; Han H; Yang L; Zhou Y
Clin Rheumatol; 2020 Aug; 39(8):2369-2378. PubMed ID: 32144625
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy.
Yoshifuji H
Mod Rheumatol; 2019 Mar; 29(2):287-293. PubMed ID: 30427262
[TBL] [Abstract][Full Text] [Related]
6. Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis.
Barra L; Yang G; Pagnoux C;
Autoimmun Rev; 2018 Jul; 17(7):683-693. PubMed ID: 29729444
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis.
Misra DP; Singh K; Rathore U; Patro P; Tomelleri A; Campochiaro C; Agarwal V; Sharma A
Autoimmun Rev; 2023 Mar; 22(3):103275. PubMed ID: 36652977
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.
Li H; Shuai Z
Heart Vessels; 2022 May; 37(5):884-894. PubMed ID: 34750666
[TBL] [Abstract][Full Text] [Related]
10. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
Decker P; Olivier P; Risse J; Zuily S; Wahl D
Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.
Kang L; Liu Y; Luo Z; Zhou Y; Chen B; Yin G; Xie Q
Front Immunol; 2023; 14():1084558. PubMed ID: 36845158
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
Nakaoka Y; Isobe M; Tanaka Y; Ishii T; Ooka S; Niiro H; Tamura N; Banno S; Yoshifuji H; Sakata Y; Kawakami A; Atsumi T; Furuta S; Kohsaka H; Suzuki K; Hara R; Maejima Y; Tsukamoto H; Takasaki Y; Yamashita K; Okada N; Yamakido S; Takei S; Yokota S; Nishimoto N
Rheumatology (Oxford); 2020 Sep; 59(9):2427-2434. PubMed ID: 31951279
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.
Batu ED; Sönmez HE; Hazırolan T; Özaltın F; Bilginer Y; Özen S
Semin Arthritis Rheum; 2017 Feb; 46(4):529-535. PubMed ID: 27515155
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of tocilizumab for the treatment of Chinese Takayasu's arteritis.
Zhou J; Chen Z; Li J; Yang Y; Zhao J; Chen H; Liu M; Sun F; Li M; Tian X; Zeng X
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):171-175. PubMed ID: 28406764
[TBL] [Abstract][Full Text] [Related]
16. Development of severe colitis in Takayasu arteritis treated with tocilizumab.
Ishii K; Shirai T; Kakuta Y; Machiyama T; Sato H; Ishii T; Harigae H; Fujii H
Clin Rheumatol; 2022 Jun; 41(6):1911-1918. PubMed ID: 35188603
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of tocilizumab for intractable Takayasu arteritis and
Isobe M; Maejima Y; Saji M; Tateishi U
J Cardiol; 2021 May; 77(5):539-544. PubMed ID: 33451862
[TBL] [Abstract][Full Text] [Related]
18. Biological treatments in giant cell arteritis & Takayasu arteritis.
Samson M; Espígol-Frigolé G; Terrades-García N; Prieto-González S; Corbera-Bellalta M; Alba-Rovira R; Hernández-Rodríguez J; Audia S; Bonnotte B; Cid MC
Eur J Intern Med; 2018 Apr; 50():12-19. PubMed ID: 29146018
[TBL] [Abstract][Full Text] [Related]
19. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
Khanna R; Preiss JC; MacDonald JK; Timmer A
Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
Osman M; Emery D; Yacyshyn E
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]